2023
Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs
Baker H, Fine R, Suter F, Allore H, Hsiao B, Chowdhary V, Lavelle E, Chen P, Hintz R, Suter L, Danve A. Implementation of a Best Practice Advisory to Improve Infection Screening Prior to New Prescriptions of Biologics and Targeted Synthetic Drugs. Arthritis Care & Research 2023 PMID: 37382043, DOI: 10.1002/acr.25181.Peer-Reviewed Original ResearchBest practice advisoryHepatitis B virusAutoimmune rheumatic diseasesBPA implementationSynthetic disease-modifying antirheumatic drugsDisease-modifying antirheumatic drugsHepatitis C virus infectionHepatitis B surface antigenC virus infectionUse of biologicsB surface antigenQuality improvement initiativesElectronic health recordsEligible patientsAntirheumatic drugsRheumatic diseasesRheumatology practiceSociety guidelinesB virusPractice advisoryComputerized decision support systemVirus infectionRoutine screeningPatient screeningPatients
2022
Concurrent use of tumor necrosis factor inhibitor and tyrosine kinase inhibitor in ankylosing spondylitis and myeloid neoplasm
Gupta A, Department of Medicine Y, Afinogenova Y, Podoltsev N, Danve A, Section of Rheumatology A, Section of Hematology D. Concurrent use of tumor necrosis factor inhibitor and tyrosine kinase inhibitor in ankylosing spondylitis and myeloid neoplasm. European Journal Of Rheumatology 2022, 9: 215-216. PMID: 35156633, DOI: 10.5152/eurjrheum.2022.21097.Peer-Reviewed Case Reports and Technical NotesMyeloid neoplasmsBiologic disease-modifying agentsTumor necrosis factor inhibitorsTyrosine kinase inhibitor imatinibNecrosis factor inhibitorsAutoimmune rheumatic diseasesDisease-modifying agentsKinase inhibitor imatinibTyrosine kinase inhibitorsMiddle-aged malesRheumatic diseasesFactor inhibitorsPatients' qualityFavorable outcomeHematologic malignanciesInhibitor imatinibBeta rearrangementInfliximabConcurrent useKinase inhibitorsCancer diagnosisPatientsNeoplasmsAppropriate casesInhibitors
2020
Managing rheumatic diseases during COVID-19
Ladani AP, Loganathan M, Danve A. Managing rheumatic diseases during COVID-19. Clinical Rheumatology 2020, 39: 3245-3254. PMID: 32895747, PMCID: PMC7476772, DOI: 10.1007/s10067-020-05387-8.Peer-Reviewed Original ResearchConceptsAutoimmune rheumatic diseasesRheumatic diseasesImmunosuppressive agentsRheumatology practiceCOVID-19Multisystem autoimmune rheumatic diseaseLong-term complicationsCOVID-19 patientsCoronavirus disease 2019 (COVID-19) pandemicCOVID-19 infectionDisease 2019 pandemicMode of spreadImmunosuppressant managementImmunosuppressant medicationsViral illnessOrgan failureClinical featuresAutoimmune diseasesSerious infectionsTreatment optionsEffective vaccineImmune systemMedicationsDiseasePatients
2019
Harnessing the power of social media: how can it help in axial spondyloarthritis research?
Reuter K, Danve A, Deodhar A. Harnessing the power of social media: how can it help in axial spondyloarthritis research? Current Opinion In Rheumatology 2019, 31: 321-328. PMID: 31045949, DOI: 10.1097/bor.0000000000000614.Peer-Reviewed Original ResearchConceptsChronic inflammatory rheumatic diseasesInflammatory rheumatic diseasesPatient-generated health dataDelivery of careMiddle-aged adultsMost patientsAxSpA patientsRheumatic diseasesStudy enrollmentAxial spondyloarthritisDisease experienceHealth educationSpondyloarthritis ResearchStudy participantsClinical researchStudy designPatientsRheumatologyHealth dataPromising studiesFurther explorationSpondyloarthritisAxSpARheumatologists
2018
Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities
Danve A, Deodhar A. Axial spondyloarthritis in the USA: diagnostic challenges and missed opportunities. Clinical Rheumatology 2018, 38: 625-634. PMID: 30588555, DOI: 10.1007/s10067-018-4397-3.Peer-Reviewed Original ResearchConceptsDiagnostic delayBack painAxial spondyloarthritisChronic inflammatory rheumatic diseasesPoor long-term outcomesInflammatory rheumatic diseasesChronic back painLong-term outcomesPrimary care physiciansPublic health initiativesQuality of lifeEarly referralPain clinicCare physiciansRheumatic diseasesAcute careSpA featuresPrimary careDiagnostic challengeSacroiliac jointSpinal functionPhysical therapyEarly diagnosisAxSpAPopulation prevalence
2017
Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus?
Danve AS, Kulkarni S. Do Tumor Necrosis Factor (TNF) Inhibitors Improve the Glycemic Control in Patients with Rheumatoid Arthritis and Concomitant Diabetes Mellitus? American Journal Of Therapeutics 2017, 24: e347-e350. PMID: 26103543, DOI: 10.1097/mjt.0000000000000297.Peer-Reviewed Original ResearchConceptsRheumatoid arthritisGlycemic controlTNF inhibitorsInsulin resistanceInsulin sensitivityTumor necrosis factor inhibitorsTumor necrosis factor alphaConcomitant rheumatoid arthritisInflammatory rheumatic diseasesNecrosis factor inhibitorsNecrosis factor alphaIncident diabetesDiabetes mellitusRheumatic diseasesFactor inhibitorsProinflammatory cytokinesFactor alphaPatientsMellitusArthritisInhibitorsDiabetesInflammationCytokinesDiseaseTreat to Target in Axial Spondyloarthritis: What Are the Issues?
Danve A, Deodhar A. Treat to Target in Axial Spondyloarthritis: What Are the Issues? Current Rheumatology Reports 2017, 19: 22. PMID: 28386759, DOI: 10.1007/s11926-017-0648-6.Peer-Reviewed Original ResearchConceptsT2T strategyAxial spondyloarthritisT2TPsoriatic Arthritis TrialRandomized clinical studyChronic medical conditionsLimited therapeutic optionsRoutine clinical practiceT strategyLack of evidenceAggressive managementPsoriatic arthritisRadiographic outcomesRheumatic diseasesRheumatoid arthritisClinical evidenceTherapeutic optionsArthritis trialsClinical trialsClinical studiesMedical conditionsClinical practiceTarget strategyArthritisSpondyloarthritis
2015
Determinants of Patient Satisfaction in an Academic Rheumatology Practice
Ku JH, Danve A, Pang H, Choi D, Rosenbaum JT. Determinants of Patient Satisfaction in an Academic Rheumatology Practice. JCR Journal Of Clinical Rheumatology 2015, 21: 256-262. PMID: 26203830, DOI: 10.1097/rhu.0000000000000263.Peer-Reviewed Original ResearchConceptsPatient satisfactionCross-sectional cohort studyAcademic rheumatology practiceChronic disease managementPatient satisfaction ratingsNon-Hispanic whitesMedian satisfaction levelRheumatologic settingCohort studyPolymyalgia rheumaticaRheumatology patientsRheumatic diseasesRheumatology practiceMean ageMedical recordsFemale genderAfternoon appointmentsSatisfaction scoresOlder ageOregon HealthPhysician performancePredictors of satisfactionDisease managementPatientsRegression analysis
2014
AB0677 Routine Assessment of Patient Index Data 3 Scores Correlate Well with Bath Ankylosing Spondylitis Disease Activity Index in the Assessment of Disease Activity and Monitoring Progression of Ankylosing Spondylitis
Danve A, Reddy A, Vakil-Gilani K, Dinno A, Deodhar A. AB0677 Routine Assessment of Patient Index Data 3 Scores Correlate Well with Bath Ankylosing Spondylitis Disease Activity Index in the Assessment of Disease Activity and Monitoring Progression of Ankylosing Spondylitis. Annals Of The Rheumatic Diseases 2014, 73: 1029. DOI: 10.1136/annrheumdis-2014-eular.1321.Peer-Reviewed Original ResearchBath Ankylosing Spondylitis Disease Activity IndexSpondylitis Disease Activity IndexDisease activity indexDisease activityRheumatoid arthritisRheumatic diseasesBaseline Bath Ankylosing Spondylitis Disease Activity IndexRoutine assessmentDisease Activity Score 28Patient Index Data 3Activity indexElectronic medical record searchPatient global assessmentMedical record searchRAPID3 scoresScore 28Disease durationPatient functionRheumatology practicePhysical functionRAPID3PatientsRecord searchGlobal assessmentBusy practice